The industry is facing an even bigger challenge to recruit, retain, and engage with patients due to COVID-19, which has delayed and de-prioritized many clinical trials across the globe. In response, IBM Watson Health has optimized IBM Clinical Development to enable decentralized trials for its clients, specifically leveraging its eCOA capabilities and its proven unified, cloud-based CDMS platform that allows remote monitoring and study control. Biorasi will be speaking as a user of this platform on how ICD is helping them overcome COVID-19-related challenges and help their Sponsors operate more efficiently.